Organoids as Models for Neoplastic Transformation

Annual Review of Pathology: Mechanisms of Disease

Volumn 11, Issue , 2016, Pages 199-220

  Neal, James T ^a   Kuo, Calvin J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3D culture; Cancer; Organoid; Organotypic

Indexed keywords

ARTICLE; CANCER CELL LINE; CANCER MODEL; CANCER TISSUE; CELL INTERACTION; CYTOPLASM; FUNCTIONAL GENOMICS; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE; ANIMAL; BIOLOGICAL MODEL; CELL TRANSFORMATION; NEOPLASM; PATHOLOGY;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; ORGANOIDS;

EID: 84971333737     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev-pathol-012615-044249     Document Type: Article

References (140)

1. Boehm JS, Hahn WC. 2011. Towards systematic functional characterization of cancer genomes. Nat. Rev. Genet. 12:487-98
2. Leighton J, Kline I, Belkin M, Legallais F, Orr HC. 1957. The similarity in histologic appearance of some human cancer and normal cell strains in sponge-matrix tissue culture. Cancer Res. 17:359-63
3. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, et al. 2012. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483:603-7
4. Egeblad M, Nakasone ES, Werb Z. 2010. Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell 18:884-901
5. Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, et al. 2007. Engineering tumors with 3D scaffolds. Nat. Methods 4:855-60
6. Infanger DW, Lynch ME, Fischbach C. 2013. Engineered culture models for studies of tumormicroenvironment interactions. Annu. Rev. Biomed. Eng. 15:29-53
7. Yeung TM, Gandhi SC, Bodmer WF. 2011. Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. PNAS 108:4382-87
8. Yeung TM, Gandhi SC,Wilding JL, Muschel R, Bodmer WF. 2010. Cancer stem cells from colorectal cancer-derived cell lines. PNAS 107:3722-27
9. DuPage M, Jacks T. 2013. Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response. Curr. Opin. Immunol. 25:192-99
10. Amos-Landgraf JM, Kwong LN, Kendziorski CM, Reichelderfer M, Torrealba J, et al. 2007. A targetselected Apc-mutant rat kindred enhances themodeling of familial human colon cancer. PNAS 104:4036-41
11. Neal JT, Peterson TS, Kent ML, Guillemin K. 2013. H. pylori virulence factor CagA increases intestinal cell proliferation byWnt pathway activation in a transgenic zebrafish model. Dis. Model. Mech. 6:802-10
12. Gateff E. 1978. Malignant neoplasms of genetic origin in Drosophila melanogaster. Science 200: 1448-59
13. Giovanella BC, Yim SO, Stehlin JS,Williams LJ Jr. 1972. Development of invasive tumors in the "nude" mouse after injection of cultured human melanoma cells. J. Natl. Cancer Inst. 48:1531-33
14. Rygaard J, Povlsen CO. 1969. Heterotransplantation of a human malignant tumour to "Nude" mice. Acta Pathol. Microbiol. Scand. 77:758-60
15. Chen JM. 1954. The cultivation in fluid medium of organised liver, pancreas and other tissues of foetal rats. Exp. Cell Res. 7:518-29
16. O'Brien LE, Zegers MM, Mostov KE. 2002. Building epithelial architecture: insights from threedimensional culture models.Nat. Rev. Mol. Cell Biol. 3:531-37
17. Li X, Nadauld L, Ootani A, Corney DC, Pai RK, et al. 2014. Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture. Nat. Med. 20:769-77
18. Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, et al. 2011. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology 141:1762-72
19. Eiraku M, Watanabe K, Matsuo-Takasaki M, Kawada M, Yonemura S, et al. 2008. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 3:519-32
20. Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, et al. 2013. Cerebral organoids model human brain development and microcephaly. Nature 501:373-79
21. Shamir ER, Pappalardo E, Jorgens DM, Coutinho K, Tsai WT, et al. 2014. Twist1-induced dissemination preserves epithelial identity and requires E-cadherin. J. Cell Biol. 204:839-56
22. Simian M, Hirai Y, Navre M, Werb Z, Lochter A, Bissell MJ. 2001. The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development 128:3117-31
23. Kovbasnjuk O, Zachos NC, In J, Foulke-Abel J, Ettayebi K, et al. 2013. Human enteroids: preclinical models of non-inflammatory diarrhea. Stem Cell Res. Ther. 4(Suppl. 1):S3
24. Ootani A, Li X, Sangiorgi E, Ho QT, Ueno H, et al. 2009. Sustained in vitro intestinal epithelial culture within aWnt-dependent stem cell niche. Nat. Med. 15:701-6
25. Eiraku M, Takata N, Ishibashi H, Kawada M, Sakakura E, et al. 2011. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 472:51-56
26. Kalabis J, Wong GS, VegaME, NatsuizakaM, Robertson ES, et al. 2012. Isolation and characterization of mouse and human esophageal epithelial cells in 3D organotypic culture. Nat. Protoc. 7:235-46
27. Qiao J, Sakurai H, Nigam SK. 1999. Branching morphogenesis independent of mesenchymal-epithelial contact in the developing kidney. PNAS 96:7330-35
28. Zhang X, Bush KT, Nigam SK. 2012. In vitro culture of embryonic kidney rudiments and isolated ureteric buds. Methods Mol. Biol. 886:13-21
29. Huch M, Gehart H, van Boxtel R,Hamer K, Blokzijl F, et al. 2015. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160:299-312
30. Takebe T, Sekine K, EnomuraM, Koike H, KimuraM, et al. 2013. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499:481-84
31. Liu Y, Stein E, Oliver T, Li Y, BrunkenWJ, et al. 2004. Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis. Curr. Biol. 14:897-905
32. Rock JR, Onaitis MW, Rawlins EL, Lu Y, Clark CP, et al. 2009. Basal cells as stem cells of the mouse trachea and human airway epithelium. PNAS 106:12771-75
33. Huch M, Bonfanti P, Boj SF, Sato T, Loomans CJ, et al. 2013. Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis. EMBO J. 32:2708-21
34. WescottMP, Rovira M, ReichertM, von Burstin J,Means A, et al. 2009. Pancreatic ductalmorphogenesis and the Pdx1 homeodomain transcription factor. Mol. Biol. Cell 20:4838-44
35. Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, et al. 2010. Lgr5+ve stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6:25-36
36. Stange DE, Koo BK, Huch M, Sibbel G, Basak O, et al. 2013. Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium. Cell 155:357-68
37. Hynds RE, Giangreco A. 2013. Concise review: The relevance of human stem cell-derived organoid models for epithelial translational medicine. Stem Cells 31:417-22
38. Lancaster MA, Knoblich JA. 2014. Organogenesis in a dish: modeling development and disease using organoid technologies. Science 345:1247125
39. ShamirER, Ewald AJ. 2014. Three-dimensional organotypic culture: experimental models of mammalian biology and disease.Nat. Rev. Mol. Cell Biol. 15:647-64
40. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, et al. 2009. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459:262-65
41. Kleinman HK, Martin GR. 2005. Matrigel: basement membrane matrix with biological activity. Semin. Cancer Biol. 15:378-86
42. Stelzner M, Helmrath M, Dunn JC,Henning SJ,HouchenCW,et al. 2012.A nomenclature for intestinal in vitro cultures. Am. J. Physiol. Gastrointest. Liver Physiol. 302:G1359-63
43. LaharN, Lei NY,Wang J, Jabaji Z, Tung SC, et al. 2011. Intestinal subepithelial myofibroblasts support in vitro and in vivo growth of human small intestinal epithelium. PLOS ONE 6:e26898
44. Yin X, Farin HF, van Es JH, Clevers H, Langer R, Karp JM. 2014. Niche-independent high-purity cultures of Lgr5+ intestinal stem cells and their progeny. Nat. Methods 11:106-12
45. Jung P, Sato T, Merlos-Suarez A, Barriga FM, Iglesias M, et al. 2011. Isolation and in vitro expansion of human colonic stem cells. Nat. Med. 17:1225-27
46. Wang F, Scoville D, He XC, Mahe MM, Box A, et al. 2013. Isolation and characterization of intestinal stem cells based on surface marker combinations and colony-formation assay. Gastroenterology 145:383-95
47. Gracz AD, Fuller MK, Wang F, Li L, Stelzner M, et al. 2013. Brief report: CD24 and CD44 mark human intestinal epithelial cell populations with characteristics of active and facultative stem cells. Stem Cells 31:2024-30
48. KarthausWR, Iaquinta PJ, Drost J, Gracanin A, van Boxtel R, et al. 2014. Identification of multipotent luminal progenitor cells in human prostate organoid cultures. Cell 159:163-75
49. Chua CW, Shibata M, Lei M, Toivanen R, Barlow LJ, et al. 2014. Single luminal epithelial progenitors can generate prostate organoids in culture. Nat. Cell Biol. 16:951-61
50. Rowe RG, Weiss SJ. 2008. Breaching the basement membrane: who, when and how? Trends Cell Biol. 18:560-74
51. Nguyen-Ngoc KV, Ewald AJ. 2013. Mammary ductal elongation and myoepithelial migration are regulated by the composition of the extracellular matrix. J. Microsc. 251:212-23
52. Nguyen-Ngoc KV, Cheung KJ, Brenot A, Shamir ER, Gray RS, et al. 2012. ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. PNAS 109:E2595-604
53. DiMarco RL, Su J, Yan KS, Dewi R, Kuo CJ, Heilshorn SC. 2014. Engineering of three-dimensional microenvironments to promote contractile behavior in primary intestinal organoids. Integr. Biol. 6:127-42
54. Katano T, Ootani A, Mizoshita T, Tanida S, Tsukamoto H, et al. 2013. Establishment of a long-term three-dimensional primary culture ofmouse glandular stomach epithelial cells within the stem cell niche. Biochem. Biophys. Res. Commun. 432:558-63
55. Spence JR, Mayhew CN, Rankin SA, Kuhar MF, Vallance JE, et al. 2011. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470:105-9
56. McCracken KW, Howell JC, Wells JM, Spence JR. 2011. Generating human intestinal tissue from pluripotent stem cells in vitro. Nat. Protoc. 6:1920-28
57. McCracken KW, Cata EM, Crawford CM, Sinagoga KL, Schumacher M, et al. 2014. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature 516:400-4
58. DyeBR, Hill DR, FergusonMA, Tsai YH,NagyMS, et al. 2015. In vitro generation of human pluripotent stem cell derived lung organoids. eLife 4:e05098
59. Suprynowicz FA, Upadhyay G, Krawczyk E, Kramer SC, Hebert JD, et al. 2012. Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells. PNAS 109:20035-40
60. Liu X, Ory V, Chapman S, Yuan H, Albanese C, et al. 2012. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am. J. Pathol. 180:599-607
61. Hanahan D,Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70
62. Hanahan D,Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144:646-74
63. Grabinger T, Luks L, Kostadinova F, Zimberlin C, Medema JP, et al. 2014. Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy. Cell Death Dis. 5:e1228
64. Calon A, Lonardo E, Berenguer-Llergo A, Espinet E, Hernando-Momblona X, et al. 2015. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat. Genet. 47:320-29
65. Shultz LD, Goodwin N, Ishikawa F, Hosur V, Lyons BL, Greiner DL. 2014. Human cancer growth and therapy in immunodeficient mouse models. Cold Spring Harb. Protoc. 2014:694-708
66. Kwong J, Chan FL, Wong KK, Birrer MJ, Archibald KM, et al. 2009. Inflammatory cytokine tumor necrosis factorα confers precancerous phenotype in an organoidmodel of normal human ovarian surface epithelial cells. Neoplasia 11:529-41
67. Matano M, Date S, Shimokawa M, Takano A, Fujii M, et al. 2015. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Nat. Med. 21:256-62
68. Bas T, Augenlicht LH. 2014. Real time analysis of metabolic profile in ex vivo mouse intestinal crypt organoid cultures. J. Vis. Exp. 93:e52026
69. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, BrooksMW, Weinberg RA. 1999. Creation of human tumour cells with defined genetic elements. Nature 400:464-68
70. Hahn WC, Weinberg RA. 2002. Rules for making human tumor cells. N. Engl. J. Med. 347:1593-603
71. Lundberg AS, Randell SH, Stewart SA, Elenbaas B, Hartwell KA, et al. 2002. Immortalization and transformation of primary human airway epithelial cells by gene transfer. Oncogene 21:4577-86
72. Sato M, Vaughan MB, Girard L, Peyton M, LeeW, et al. 2006. Multiple oncogenic changes (K-RASV12, p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res. 66:2116-28
73. Sasai K, Sukezane T, Yanagita E, Nakagawa H, Hotta A, et al. 2011. Oncogene-mediated human lung epithelial cell transformation produces adenocarcinoma phenotypes in vivo. Cancer Res. 71:2541-49
74. Leung CT, Brugge JS. 2012. Outgrowth of single oncogene-expressing cells from suppressive epithelial environments. Nature 482:410-13
75. Koo BK, Stange DE, Sato T, KarthausW, Farin HF, et al. 2012. Controlled gene expression in primary Lgr5 organoid cultures. Nat. Methods 9:81-83
76. Schwank G, Koo BK, Sasselli V, Dekkers JF, Heo I, et al. 2013. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 13:653-58
77. Schwank G, Andersson-Rolf A, Koo BK, Sasaki N, Clevers H. 2013. Generation of BAC transgenic epithelial organoids. PLOS ONE 8:e76871
78. Boj SF, Hwang CI, Baker LA, Chio II, Engle DD, et al. 2015. Organoid models of human and mouse ductal pancreatic cancer. Cell 160:324-38
79. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-67
80. Nadauld LD, Garcia S, Natsoulis G, Bell JM, Miotke L, et al. 2014. Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer. Genome Biol. 15: 428
81. Onuma K, Ochiai M, Orihashi K, Takahashi M, Imai T, et al. 2013. Genetic reconstitution of tumorigenesis in primary intestinal cells. PNAS 110:11127-32
82. Cong L, Ran FA, CoxD,Lin S, Barretto R, et al. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339:819-23
83. Mali P, Esvelt KM, Church GM. 2013. Cas9 as a versatile tool for engineering biology. Nat. Methods 10:957-63
84. Drost J, van Jaarsveld RH, Ponsioen B, Zimberlin C, van Boxtel R, et al. 2015. Sequential cancer mutations in cultured human intestinal stem cells. Nature 521:43-47
85. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, et al. 2009. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324: 1457-61
86. Stratton MR, Campbell PJ, Futreal PA. 2009. The cancer genome. Nature 458:719-24
87. Pon JR, Marra MA. 2015. Driver and passenger mutations in cancer. Annu. Rev. Pathol. Mech. Dis. 10:25-50
88. Cancer Genome Atlas Netw. 2012. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330-37
89. Wang K, Yuen ST, Xu J, Lee SP, Yan HH, et al. 2014. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat. Genet. 46:573-82
90. Chen X, Leung SY, Yuen ST, Chu KM, Ji J, et al. 2003. Variation in gene expression patterns in human gastric cancers. Mol. Biol. Cell 14:3208-15
91. Watanabe K, Ueno M, Kamiya D, Nishiyama A, MatsumuraM, et al. 2007. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25:681-86
92. Cowley GS,Weir BA, Vazquez F, Tamayo P, Scott JA, et al. 2014. Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies. Sci. Data 1:140035
93. Shalem O, Sanjana NE,Hartenian E, Shi X, Scott DA, et al. 2014. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343:84-87
94. Chen S, Sanjana NE, Zheng K, Shalem O, Lee K, et al. 2015. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160:1246-60
95. Nowell PC. 1976. The clonal evolution of tumor cell populations. Science 194:23-28
96. Gould SJ, Eldredge N. 1993. Punctuated equilibrium comes of age. Nature 366:223-27
97. Sottoriva A, KangH,MaZ,GrahamTA, SalomonMP, et al. 2015.ABig Bang model of human colorectal tumor growth. Nat. Genet. 47:209-16
98. Greaves M, Maley CC. 2012. Clonal evolution in cancer. Nature 481:306-13
99. Folkman J. 2006. Angiogenesis. Annu. Rev. Med. 57:1-18
100. Hanahan D, Coussens LM. 2012. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21:309-22
101. Meacham CE, Morrison SJ. 2013. Tumour heterogeneity and cancer cell plasticity. Nature 501: 328-37
102. Valastyan S, Weinberg RA. 2011. Tumor metastasis: molecular insights and evolving paradigms. Cell 147:275-92
103. Calderwood SK. 2013. Tumor heterogeneity, clonal evolution, and therapy resistance: an opportunity for multitargeting therapy. Discov. Med. 15:188-94
104. Beerenwinkel N, Antal T, Dingli D, Traulsen A, Kinzler KW, et al. 2007. Genetic progression and the waiting time to cancer. PLOS Comput. Biol. 3:e225
105. Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, et al. 2010. Accumulation of driver and passenger mutations during tumor progression. PNAS 107:18545-50
106. Maley CC, Galipeau PC, Li X, Sanchez CA, Paulson TG, Reid BJ. 2004. Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus. Cancer Res. 64:3414-27
107. Negrini S, Gorgoulis VG, Halazonetis TD. 2010. Genomic instability-an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 11:220-28
108. Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z. 2008. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev. Cell 14:570-81
109. Nelson CM, Bissell MJ. 2005. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin. Cancer Biol. 15: 342-52
110. Van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, et al. 2015. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161:933-45
111. Endo H, Okami J, Okuyama H, Kumagai T, Uchida J, et al. 2013. Spheroid culture of primary lung cancer cells with neuregulin 1/HER3 pathway activation. J. Thorac. Oncol. 8:131-39
112. Kimura M, Endo H, Inoue T, Nishino K, Uchida J, et al. 2015. Analysis of ERBB ligand-induced resistance mechanism to crizotinib by primary culture of lung adenocarcinoma with EML4-ALK fusion gene. J. Thorac. Oncol. 10:527-30
113. GaoD, Vela I, Sboner A, Iaquinta PJ, KarthausWR, et al. 2014. Organoid cultures derived from patients with advanced prostate cancer. Cell 159:176-87
114. Kondo J, Endo H, Okuyama H, Ishikawa O, Iishi H, et al. 2011. Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer. PNAS 108:6235-40
115. Gillet JP, Calcagno AM, Varma S, Marino M, Green LJ, et al. 2011. Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. PNAS 108:18708-13
116. Gillet JP, Varma S, Gottesman MM. 2013. The clinical relevance of cancer cell lines. J. Natl. Cancer Inst. 105:452-58
117. Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A, et al. 2012. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483:570-75
118. Domcke S, Sinha R, Levine DA, Sander C, Schultz N. 2013. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat. Commun. 4:2126
119. Sugaya M, Takenoyama M, Osaki T, Yasuda M, Nagashima A, et al. 2002. Establishment of 15 cancer cell lines from patients with lung cancer and the potential tools for immunotherapy. Chest 122: 282-88
120. Grozinsky-Glasberg S, Shimon I,RubinfeldH. 2012. The role of cell lines in the study of neuroendocrine tumors. Neuroendocrinology 96:173-87
121. Tentler JJ, Tan AC, Weekes CD, Jimeno A, Leong S, et al. 2012. Patient-derived tumour xenografts as models for oncology drug development. Nat. Rev. Clin. Oncol. 9:338-50
122. DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, et al. 2011. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat. Med. 17:1514-20
123. Arias M, Fan H. 2014. The saga of XMRV: A virus that infects human cells but is not a human virus. Emerg. Microbes Infect. 3:e25
124. Ranga A, Gjorevski N, Lutolf MP. 2014. Drug discovery through stem cell-based organoidmodels. Adv. Drug Deliv. Rev. 69-70:19-28
125. Astashkina A, Grainger DW. 2014. Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments. Adv. Drug Deliv. Rev. 69-70:1-18
126. Lutolf MP, Hubbell JA. 2005. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23:47-55
127. Kalluri R, Zeisberg M. 2006. Fibroblasts in cancer. Nat. Rev. Cancer 6:392-401
128. Becker JC, Andersen MH, Schrama D, Straten PT. 2013. Immune-suppressive properties of the tumor microenvironment. Cancer Immunol. Immunother. 62:1137-48
129. Stetler-StevensonWG, Aznavoorian S, Liotta LA. 1993. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9:541-73
130. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, et al. 2005. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-48
131. Bhowmick NA, Neilson EG, Moses HL. 2004. Stromal fibroblasts in cancer initiation and progression. Nature 432:332-37
132. DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, et al. 2011. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 1:54-67
133. Kuang DM, Zhao Q, Peng C, Xu J, Zhang JP, et al. 2009. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J. Exp. Med. 206:1327-37
134. Yang P, Li QJ, Feng Y, Zhang Y, Markowitz GJ, et al. 2012. TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 22:291-303
135. Wyckoff JB, Wang Y, Lin EY, Li JF,Goswami S, et al. 2007. Direct visualization ofmacrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 67:2649-56
136. Junttila MR, de Sauvage FJ. 2013. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501:346-54
137. Faget J, Biota C, Bachelot T, Gobert M, Treilleux I, et al. 2011. Early detection of tumor cells by innate immune cells leads to Treg recruitment through CCL22 production by tumor cells. Cancer Res. 71:6143-52
138. Ingthorsson S, Sigurdsson V, Fridriksdottir A Jr, Jonasson JG, Kjartansson J, et al. 2010. Endothelial cells stimulate growth of normal and cancerous breast epithelial cells in 3D culture. BMC Res. Notes 3:184
139. Woods GM, Lowenthal RM. 1987. Human T lymphocyte colonies require IL2 and are inhibited by anti-Tac. Immunol. Cell Biol. 65(Pt. 1):97-101
140. Leighton J. 1954. The growth patterns of some transplantable animal tumors in sponge matrix tissue culture. J. Natl. Cancer Inst. 15:275-93